Literature DB >> 11195273

Preventing infections associated with indwelling intravascular access devices.

.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 11195273

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


× No keyword cloud information.
  9 in total

Review 1.  Standardized definitions for hemodialysis vascular access.

Authors:  Timmy Lee; Michele Mokrzycki; Louise Moist; Ivan Maya; Miguel Vazquez; Charmaine E Lok
Journal:  Semin Dial       Date:  2011-09-09       Impact factor: 3.455

2.  Evaluating Approaches for the Diagnosis of Hemodialysis Catheter-Related Bloodstream Infections.

Authors:  Friederike Quittnat Pelletier; Mohammad Joarder; Susan M Poutanen; Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-01       Impact factor: 8.237

3.  Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Steven D Soroka; Adeera Levin; Jennifer MacRae; Karthik Tennankore; Jo-Anne S Wilson; Robert G Weaver; Pietro Ravani; Robert R Quinn; Marcello Tonelli; Mercedeh Kiaii; Paula Mossop; Nairne Scott-Douglas
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-15       Impact factor: 8.237

Review 4.  Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis.

Authors:  Molly Fisher; Ladan Golestaneh; Michael Allon; Kenneth Abreo; Michele H Mokrzycki
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-05       Impact factor: 8.237

5.  Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449].

Authors:  Brenda R Hemmelgarn; Louise Moist; Rachel M Pilkey; Charmaine Lok; Marc Dorval; Paul Y W Tam; Murray J Berall; Martine LeBlanc; Edwin B Toffelmire; Braden J Manns; Nairne Scott-Douglas
Journal:  BMC Nephrol       Date:  2006-04-11       Impact factor: 2.388

6.  Hemodialysis Infection Prevention Protocols Ontario-Shower Technique (HIPPO-ST): A Pilot Randomized Trial.

Authors:  S Daisy Kosa; Amiram Gafni; Andrew A House; JulieAnn Lawrence; Louise Moist; Bharat Nathoo; Paul Tam; Alicia Sarabia; Lehana Thabane; George Wu; Charmaine E Lok
Journal:  Kidney Int Rep       Date:  2016-11-08

7.  Hemodialysis Tunneled Catheter-Related Infections.

Authors:  Lisa M Miller; Edward Clark; Christine Dipchand; Swapnil Hiremath; Joanne Kappel; Mercedeh Kiaii; Charmaine Lok; Rick Luscombe; Louise Moist; Matthew Oliver; Jennifer MacRae
Journal:  Can J Kidney Health Dis       Date:  2016-09-27

8.  Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trial.

Authors:  Pavlina Richtrova; Jan Mares; Lukas Kielberger; Jan Klaboch; Jaromir Eiselt; Tomas Reischig
Journal:  BMC Nephrol       Date:  2021-01-28       Impact factor: 2.388

9.  Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.

Authors:  Jennifer K Broom; Stacey O'Shea; Sridevi Govindarajulu; E Geoffrey Playford; Carmel M Hawley; Nicole M Isbel; Scott B Campbell; David W Mudge; Sally Carpenter; Barbara C Johnson; Neil P Underwood; David W Johnson
Journal:  BMC Nephrol       Date:  2009-08-20       Impact factor: 2.388
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.